Skip to main content
. Author manuscript; available in PMC: 2020 May 13.
Published in final edited form as: JACC Cardiovasc Interv. 2019 Apr 10;12(9):835–843. doi: 10.1016/j.jcin.2019.01.224

Table 2:

Adverse events

General Anesthesia N=3236 Operator Directed Sedation N=1188 p
Total 212 (6.6%) 41 (3.5%) <0.001
30 day in-hospital mortality 0 (0%) 0 (0%) 1.00
Cardiac arrest 25 (0.8%) 2 (0.2%) 0.04
New arrhythmia 78 (2.4%) 15 (1.3%) 0.03
New heart valve regurgitation 2 (<0.1%) 0 (0%) 1.00
Tamponade 0 (0%) 1 (<0.1%) 0.60
Air embolus 0 (0%) 0 (0%) 1.00
Embolic stroke 3 (0.1%) 0 (0%) 0.69
Device malposition 1 (<0.1%) 0 (0%) 1.00
Device embolization 4 (0.1%) 2 (0.2%) 1.00
Airway event NA 3 (0.3%) NA
Initiation of dialysis 1 (<0.1%) 0 (0%) 1.00
New endotracheal intubation 30 (0.9%) 7 (0.6%) 0.36
Initiation of extracorporeal membrane oxygenation 9 (0.3%) 0 (0%) 0.15
Initiation of ventricular assist device 3 (0.1%) 1 (<0.1%) 1.00
Bleeding event 32 (1.0%) 11 (0.9%) 0.99
Unplanned cardiac/vascular/other surgery 7 (0.2%) 0 (0%) 0.24
Vascular complication 43 (1.3%) 4 (0.3%) 0.01
Repeat catheterization 7 (0.2%) 1 (<0.1%) 0.60
Other 13 (0.4%) 3 (0.3%) 0.65